Biolase stock forecast.

BIOLASE ( NASDAQ: BIOL) stock price plummeted 30% during early hours on Thursday as the company priced an underwritten public offering of 75K units, with each unit consisting of one share of ...WebBiolase (BTH) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.Real time Biolase (BIOL) stock price quote, stock graph, news & analysis.Nov 30, 2023 · BIOLASE stock has a strong buy rating from 3 analysts, who predict an increase of 6,566.47% to $113.33 in the next 12 months. The average price target is $100, with a range of $40 to $200. The stock has a low revenue growth rate and a high EPS loss in the past year.

Net loss attributable to common stockholders for the quarter ended September 30, 2023 was $4.6 million, or $3.89 per share, compared to a net loss of $8.4 million, or $110.36 per share (as ...The BIOLASE stock prediction results are shown below and presented as a graph, table and text information. BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 22.25. Today 200 Day Moving Average is the resistance level (17.28 $).

BIOLASE Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast BIOLASE INC historical stock prices and determine the direction of BIOLASE INC's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.What this means: InvestorsObserver gives Biolase Inc (BIOL) an overall rank of 34, which is below average. Biolase Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.13 Apr 2018. Dental laser company 'exploring strategic alternatives' as CFO takes over on interim basis. Biolase stock price: past 12 months.

Find real-time NKLA - Nikola Corp stock quotes, company profile, news and forecasts from CNN Business.Web

Find the latest analyst research for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.

BIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of …Based on short-term price targets offered by three analysts, the average price target for Biolase comes to $15.67. The forecasts range from a low of $3.00 to a high of $40.00. The average price ...Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...Real time Biolase (BIOL) stock price quote, stock graph, news & analysis.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Workhorse Group share forecasts, stock quote and buy / sell signals below. According to present data Workhorse Group's WKHS shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Institutional Holdings information can be used to gauge the volatility and value on the company’s stock. $173.46 -0.20. VinFast Auto Ltd. Ordinary Shares. $8.11 +0.06 +0.75%. Find the latest ...WebThe projected low price target is $2.50 while the price target rests at a high of $3.00. In that case, then, we find that the latest price level in today’s session is -109.79% off the targeted high while a plunge would see the stock gain -74.83% from the levels at last check today.. Biolase Inc (BIOL) estimates and forecasts

Biolase, Inc. (BIOL) stock forecast and price target. Find the latest Biolase, Inc. BIOL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. The Series J Convertible Preferred Stock has a term of one (1) year and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $3.26.Forecast for July 2025. It is predicted that the price of one BIOLASE share in will be in the range of $0.95 to $1.11. The width of this range will be $0.17 (15.15%). The average price is $1.05, which is $0.07 higher than the average price of the previous month.The Plug Power stock price fell by -2.38% on the last day (Wednesday, 22nd Nov 2023) from $3.57 to $3.48. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 5.97% from a day low at $3.44 to a day high of $3.64. The price has fallen in 8 of the last 10 days and is down by -42.19% for this period.WebStock BIOL November 24, 2023 NASDAQ 20 minutes delay $1.22 Open 1.27 Low ... BIOLASE is the global market leader in all-tissue & soft-tissue dental laser systems that are #AdvancingDentistry ... BIOLASE (BIOL) Stock Forecast & Price Target $1.10 -0.05 (-4.35%) (As of 11/29/2023 ET) Compare Today's Range $1.10 $1.20 50-Day Range $1.10 $1.89 52-Week Range $1.07 $99.50 Volume 88,335 shs Average Volume 156,585 shs Market Capitalization $2.53 million P/E Ratio N/A Dividend Yield N/A Price Target $77.00

Detailed statistics for BIOLASE, Inc. (BIOL) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The average ...

The BIOL stock price is -6718.18% off its 52-week high price of $97.50 and 25.17% above the 52-week low of $1.07. If we look at the company’s 10-day average daily trading volume, we find that it stood at 91120.0 shares traded. The 3-month trading volume is 321.12K shares. ... Biolase Inc (BIOL) estimates and forecasts.BIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of Buy and a price target of $513.50, with a forecasted upside of 30,132.6%. The company reported record revenue and earnings in the second quarter of 2023, and announced a public offering of preferred stock and warrants.Forecast for July 2025. It is predicted that the price of one BIOLASE share in will be in the range of $0.95 to $1.11. The width of this range will be $0.17 (15.15%). The average price is $1.05, which is $0.07 higher than the average price of the previous month.While BIOLASE's business continues to show respectable growth, cash burn remains a major issue. Click here to find out why investors should continue to avoid BIOL stock.BIOLASE stock has a strong buy rating from 3 analysts, who predict an increase of 6,566.47% to $113.33 in the next 12 months. The average price target is …Analyst projections state that BIOL is forecast to be at a low of $4.00 and a high of $40.00. In order for the stock price to hit the forecast high, the stock would need to plunge -2295.21% from its current level, while the stock would need to crash -139.52% from its current level to reach the projected low. Biolase Inc (BIOL) estimates and ...According to 30 stock analysts, the average 12-month stock price forecast for Tesla stock is $238.87, which predicts a decrease of -2.16%. The lowest target is $85 and the highest is $380. On average, analysts rate Tesla stock as a hold.WebPredicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...

See BIOLASE, Inc. (BIOL) history of stock splits. Includes date and ratio.Web

The Biolase Inc (BIOL) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $21.75, representing a +1,639% increase from the current price of $1.2506. The highest analyst price target is $42.41, and the lowest is $1.0934.

Find the latest BIOLASE, Inc. (BIOL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.AT&T Stock Forecast 12-07-2023. Forecast target price for 12-07-2023: $ 16.48. Negative dynamics for AT&T shares will prevail with possible volatility of 1.632%. Pessimistic target level: 16.40. Optimistic target level: 16.67.Web21 sept 2023 ... Shares of Biolase saw signs of life in the stock market today. The ... Instead of waiting for its share price to climb, it has conducted a ...Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...BIOLASE, Inc. (BIOL) share price prediction for 2023, 2024, 2025, 2026 and 2027. BIOL one year forecast. Biolase stock monthly and weekly forecasts.Nov 27, 2023 · The Biolase stock price fell by -6.45% on the last day (Monday, 27th Nov 2023) from $1.24 to $1.16. During the last trading day the stock fluctuated 10.00% from a day low at $1.10 to a day high of $1.21. The price has been going up and down for this period, and there has been a 0.87% gain for the last 2 weeks. Dec 1, 2023 · The Soligenix, Inc stock price fell by -25.53% on the last day (Friday, 1st Dec 2023) from $0.98 to $0.730. During the last trading day the stock fluctuated 25.14% from a day low at $0.711 to a day high of $0.89. The price has been going up and down for this period, and there has been a 80.56% gain for the last 2 weeks. The average BIOLASE stock forecast 2028 represents a -25.15% decrease from the last price of $1.14999997615814. For BIOLASE stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BIOLASE stock forecast of $1.91, a high forecast of $3.64, and a low forecast of $0.72.hace 3 días ... $0.24. CEI 0.49%. BIOLASE Inc. $1.15. BIOL 5.50%. SINTX Technologies Inc. $0.38. SINT 7.85%. T2 Biosystems Inc. $3.90. TTOO 10.17%. Astra Space ...

13 Apr 2018. Dental laser company 'exploring strategic alternatives' as CFO takes over on interim basis. Biolase stock price: past 12 months.Biolase Inc. BIOL (U.S.: Nasdaq) Overview News Biolase Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-158.42 Market Cap $2.87 M 2.30 M...Lake Street Adjusts Price Target on Biolase to $0.40 From $1.50, Maintains Buy Rating May. 31: MT Lake Street Assumes Biolase at Buy With $1.50 Price Target Jan. 20: MT Lake Street Initiates Biolase at Buy, Sets Price Target at $12 2022: MTEvelo Biosciences Inc. $0.40. EVLO 1.25% ; Vivos Therapeutics Inc. $19.90. VVOS 18.78% ; Femasys Inc. $0.93. FEMY 2.33% ; Histogen Inc. $0.33. HSTO 2.19% ; BIOLASE ...Instagram:https://instagram. best mortgage lenders with lowest closing costsspy holdings by weightjfk 50 cent coin valuestock market now dow BIOLASE Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 1.19. Negative dynamics for BIOLASE shares will prevail with possible volatility of 4.961%. Pessimistic target level: 1.17. Optimistic target level: 1.23.21 sept 2023 ... Shares of Biolase saw signs of life in the stock market today. The ... Instead of waiting for its share price to climb, it has conducted a ... sdsstockmortgage loan for business owners hace 5 días ... BIOLASE Stock Down 4.3 %. BIOL stock opened at $1.10 on ... Audioboom Group (LON:BOOM) Stock Price Passes Below 200-Day Moving Average of $206.35 ... 1976 quarter dollar value Dec 1, 2023 · BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants PR Newswire Sep 18, 2023 8:30pm With the interplay of data, predictions, and real-time performance, BIOLASE's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale.